1) Clinical Trial: EVALUATION OF DIET AND INDICATION-SPECIFIC NUTRACEUTICAL ADMINISTRATION [VARYING PROPORTIONS OF TRIPHALA, TURKEY RHUBARB, FRUCTOOLIGOSACCHARIDES, ] INDIVIDUALLY AND THEIR CONCAMITANT FACILITATION OF GASTROINTESTINAL MOTILITY AND SUBJECTIVE DIGESTIVE HEALTH IN HUMAN SUBJECTS. STUDY OF PROPOSED ReCLEANSE FORMULATION.
Clinical Research Division Biologic Nutrigenomic Health Research Corp.
688-2397 King George Hwy, BC V4A 7E9
Original post: September 9, 2010
North Americans have adopted dietary habits and overall lifestyle that is contributing to morbidity of multiple types. The most obvious consequence of our new age ways is the ever-growing incidence of obesity which statistics demonstrate has reached an alarming 25 % of the population. The less apparent concurrent or consequential metabolic developments include diabetes and the less obvious complication of advanced subclinical inflammation.
Research conducted by Franco Cavaleri @ BNHRC has defined the metabolic and biochemical link between insulin resistance and prostaglandin production from cyclooxygenase induction. This research has also shed light on the pathway that concurrently leads to thromoboxane elevation and the consequential uncontrolled acceleration of clot formation and increased risk for cardiovascular disease. This subclincal inflammation is also linked to nitric oxide and the regulation of blood pressure.
As opposed to dealing with each of these related co-existing ailments symptomatically we have embarked on a project to create awareness and provide an easy to use actionable plan for afflicted consumers……
Ultimate Objective of the trial: A previously existing formulation in this category was not effective enough to deliver the intended result. After extensive investigation of the formulation by the research designer it was determined that many of the ingredients were not being used at research documented levels to produce the intended pharmacological outcome. The entire formulation rationale – (ingredient synergy versus individual ingredient pharmacology) was reworked and a new attempt made with the formulation. A new nutraceutical and dietary program were theorized, researched and tried by subjects to demonstrate efficacy, convenience for compliance and safety. The objective was ultimately to produce a SYSTEM of lifestyle changes wedded to nutraceutical pharmacology that promotes healthy intestinal motility and improved general health that would allow spontaneous healing of the comorbid states….
Challenge 1: Controllable Laxation. The challenge that we are presented with is to find the nutraceutical activity potent enough to deliver a noticeably functional result while preventing intrusion on the lifestyle. The formula will deliver an underlying pharmacology that promotes intestinal motility and induces mucosal lining regeneration…